ArticleBiochemia medica2025
Interfering heterophile antibodies as the cause of persistently falsely elevated high-sensitivity troponin I on Alinity i: a case report.
Article in Biochemia medica, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- False-Positive High-Sensitivity Troponin I in Clinical Practice.JACC. Case reports · 2026Article
- Clinical Impact of Macrotroponin on Immunometric Troponin Assays: A Cross-Analytical Case Evaluation.International journal of molecular sciences · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Hereby we describe a case of a 59-year-old female patient with persistently elevated high-sensitivity troponin I (hs-TnI) over the course of almost four years measured on Alinity i with the corresponding assay (Abbott Laboratories, Chicago, USA). The patient underwent multiple extensive cardiological evaluations, but none of them suggested acute or chronic cardiac damage. Therefore, interference in measurement was suspected by the attending cardiologist and a detailed, stepwise laboratory investigation was undertaken in the sample with initial hs-TnI result of 2077 ng/L. Serial sample dilutions (1:2,1:5,1:10) did not match the expected, calculated hs-TnI concentrations, yielding both huge positive biases (62, 109 and 139%, respectively) and absolute differences (639, 453 and 290 ng/L, respectively). Precipitation with polyethylene-glycol, pretreatment in heterophilic blocking tubes (HBT) and immunoglobulin G depletion yielded hs-TnI results below the assay's diagnostic cut-off (< 15.6 ng/L). Alternate hs-TnI immunoassays (Siemens Healthineers, Beckman Coulter and Snibe) and measurement with the high-sensitivity troponin T (hs-TnT) assay yielded results below assays' specific cut-off values. This investigation confirmed that results of hs-TnI obtained by the Abbott assay were spuriously elevated. Significant lowering of hs-TnI after HBT pretreatment indicated that heterophile antibodies are the most probable source of interference. Based on this finding, it was entered in the patient's medical record that future determinations of cardiac troponin should be performed with an alternate hs-TnI or hs-TnT assay. This case emphasizes that analytical interferences are usually immunoassay-dependent. Evaluation of laboratory results in the clinical context and close collaboration between laboratory and clinical staff is crucial for their recognition.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.